A Study of LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis
Clinical trial NCT06099535 · COMPLETED
Trial details
- NCT number
- NCT06099535
- Sponsor
- Lynk Pharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2022-12-29
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.